Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Jan 27;28(1):51.
doi: 10.1186/s40001-023-01007-8.

Comparison of the effect of oral and vaginal misoprostol on labor induction: updating a systematic review and meta-analysis of interventional studies

Affiliations
Meta-Analysis

Comparison of the effect of oral and vaginal misoprostol on labor induction: updating a systematic review and meta-analysis of interventional studies

Maryam Rahimi et al. Eur J Med Res. .

Abstract

Objectives: This study is aimed to compare the effect of oral misoprostol with vaginal misoprostol to induce labor as a systematic review and meta-analysis.

Methods: Electronic databases including PubMed [Medline], Scopus, Web of science, Embase, Ovid, Cochrane library, and ClinicalTrials.gov were searched using the relevant keywords. All RCTs comparing the effect of oral vs vaginal misoprostol on labor induction were considered. The Cochrane Risk of Bias checklist was used for assessing quality of included RCTs. All statistical analyses were completed using STATA (Version 16) and Revman (Version 5).

Results: Thirty-three RCTs with 5162 patients (1560 in oral and 2602 in vaginal groups) were included in this meta-analysis. Labor induction length did differ significantly between the two routes of misoprostol administration [Standardized Mean Difference: 0.40 h, 95% confidence interval (CI) 0.34, 0.46; I2: 66.35%; P = 0.04]. In addition, the risk of neonatal death, tachysystole, uterine hyperstimulation, preeclampsia, non-FHR and abortion was lower in the oral misoprostol group and the risk of hypertonus, PROM, oxytocin need and cesarean fever was higher in this group than the vaginal misoprostol group.

Conclusions: Based on results of this meta-analysis, it can be inferred that currently, clinical specialists can decide to use this drug orally or vaginally on a case-by-case basis, depending on the condition of the pregnant mother and the baby.

Keywords: Labor induction; Meta-analysis; Oral misoprostol; Systematic review; Vaginal misoprostol.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow diagram for related article numbers which included in meta-analysis
Fig. 2
Fig. 2
Forest plot for pooled weighted mean difference of induction labor length in oral and vaginal misoprostol groups
Fig. 3
Fig. 3
Results of publication bias and effect of age and follow-up duration on pooled weighted mean difference (WMD)
Fig. 4
Fig. 4
Forest plot for pooled risk ratio of Apgar < 7 at 1 min in oral than vaginal misoprostol groups
Fig. 5
Fig. 5
Forest plot for pooled risk ratio of Apgar < 7 at 5 min in oral than vaginal misoprostol groups

Similar articles

Cited by

References

    1. Cunningham FG, et al. Overview of obstetrics. Williams obstetrics. 23. New York: McGraw-Hill; 2010.
    1. Ghasemi V, et al. Effective interventions for the induction of labor: a systematic review. Iran J Obstet, Gynecol Infertil. 2018;21(1):90–104.
    1. Takakura S, et al. The successful use of nitroglycerin for uterine hyperstimulation with fetal heart rate abnormality caused by a controlled-release dinoprostone vaginal delivery system (propess): a case report. Medicina. 2021;57(5):478. doi: 10.3390/medicina57050478. - DOI - PMC - PubMed
    1. Tan P, et al. Predictors of newborn admission after labour induction at term: Bishop score, pre-induction ultrasonography and clinical risk factors. Singapore Med J. 2008;49(3):193. - PubMed
    1. Nagpal MB, Raghunandan C, Saili A. Oral misoprostol versus intracervical prostaglandin E2 gel for active management of premature rupture of membranes at term. Int J Gynecol Obstet. 2009;106(1):23–26. doi: 10.1016/j.ijgo.2009.03.014. - DOI - PubMed

LinkOut - more resources